Prasugrel a strong contender in acute coronary syndromes

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1613, 2007-01, pp. : 7-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prasugrel: A Guide to Its Use in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention in the US

By Lyseng-Williamson Katherine A.  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 3, 2012-06 ,pp. : 207-216

Adis International

Access to resources Recommend Favorite

Prasugrel: A Review of its Use in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

By Duggan Sean T.   Keating Gillian M.  

Drugs, Vol. 69, Iss. 12, 2009-08 ,pp. : 1707-1726

Adis International

Access to resources Recommend Favorite

Role of Prasugrel, a Novel P2Y 12 Receptor Antagonist, in the Management of Acute Coronary Syndromes

By Baker William L.   White C. Michael  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 4, 2009-08 ,pp. : 213-229

Adis International

Access to resources Recommend Favorite

Fondaparinux in acute coronary syndromes

By Chaturvedi Vivek   Karthikeyan Ganesan  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 12, 2009-12 ,pp. : 1615-1623

Informa Healthcare

Access to resources Recommend Favorite

Acute Coronary Syndromes in the Elderly

By Kyriakides Zenon S.   Kourouklis Spyros   Kontaras Konstantinos  

Drugs & Aging, Vol. 24, Iss. 11, 2007-01 ,pp. : 901-912

Adis International

Access to resources Recommend Favorite